Comparison of the characteristics of uncommon epidermal growth factor receptor (EGFR) mutations and EGFR-tyrosine kinase inhibitor treatment in patients with non-small cell lung cancer from different ethnic groups

Patients with epidermal growth factor receptor (EGFR)-sensitive mutations generally have a significantly higher objective response rate (ORR) and longer progression-free survival (PFS) after EGFR-tyrosine kinase inhibitor (TKI) treatment. However, the efficacy of EGFR-TKIs in the case of uncommon EG...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiao, Cui, Yanyan, Zhang, Jian, Kenjiabieke, Jiayideng, Aerxiding, Patiguli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185161/
https://www.ncbi.nlm.nih.gov/pubmed/32346412
http://dx.doi.org/10.3892/etm.2020.8612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185161/
https://www.ncbi.nlm.nih.gov/pubmed/32346412
http://dx.doi.org/10.3892/etm.2020.8612

Ejemplares similares